Anti-Müllerian Hormone and Metabolic Dysfunction in Polycystic Ovary Syndrome: A Cross-Sectional Study with Age-Stratified Analysis and BMI Mediation

Studied

Whether anti-Müllerian hormone adds information about metabolic risk in polycystic ovary syndrome.

Who / model

A single-center cross-sectional study of 123 women with polycystic ovary syndrome, including 43 adolescents and 80 reproductive-aged women.

Studied dose & schedule

Dose and schedule have not yet been extracted for this summary.

Found

Higher hormone levels correlated with lower body mass index and LDL cholesterol, but higher testosterone. Its association with insulin resistance weakened after adjusting for body mass index. A model adding hormones and age did not clearly outperform body mass index alone.

Limits

Cross-sectional associations do not establish a causal pathway. The prediction model still needs validation in other patient groups.

Read summary source ↗ · Prepared 9/15/2026 · AI-assisted, source-based summary